ProPhase Labs (PRPH) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for ProPhase Labs (PRPH) over the last 15 years, with Q3 2025 value amounting to -$0.16.
- ProPhase Labs' EPS (Weighted Average and Diluted) rose 5428.57% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.99, marking a year-over-year decrease of 2838.71%. This contributed to the annual value of -$0.19 for FY2024, which is 8085.64% up from last year.
- According to the latest figures from Q3 2025, ProPhase Labs' EPS (Weighted Average and Diluted) is -$0.16, which was up 5428.57% from -$0.11 recorded in Q2 2025.
- In the past 5 years, ProPhase Labs' EPS (Weighted Average and Diluted) ranged from a high of $0.69 in Q4 2021 and a low of -$0.51 during Q4 2023
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.11 (2025), whereas its average is -$0.05.
- As far as peak fluctuations go, ProPhase Labs' EPS (Weighted Average and Diluted) skyrocketed by 1990137.5% in 2021, and later crashed by 130000.0% in 2024.
- Over the past 5 years, ProPhase Labs' EPS (Weighted Average and Diluted) (Quarter) stood at $0.69 in 2021, then crashed by 111.59% to -$0.08 in 2022, then plummeted by 537.5% to -$0.51 in 2023, then skyrocketed by 92.47% to -$0.04 in 2024, then tumbled by 316.55% to -$0.16 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.16 for Q3 2025, versus -$0.11 for Q2 2025 and -$0.13 for Q1 2025.